Navigation Links
HealthAware Introduces Its SleepAware Cardiovascular Disease Module
Date:10/22/2007

their public outreach.

When patients use the online SleepAware module, it considers the following risk factors:

-- Obesity -- Diabetes -- Neck size

-- Loud snoring -- High blood pressure -- Smoking

-- Sleep/fatigue during

the day

About HealthAware

HealthAware, a division of Byrne Healthcare, is a respected market leader offering innovative services to healthcare providers that drive more at-risk patients through their door. HealthAware is dedicated to halting the progress of major diseases in the U.S. Our mission is to provide services and systems that save patients, while enabling select healthcare organizations to thrive and grow their market share. The end result being longer, healthier lives for consumers and healthcare organizations that are more vital and productive.


'/>"/>
SOURCE HealthAware
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. TI Cycles Introduces Foldman
3. Canada Introduces Mandatory Nutrition Labeling
4. Amgen introduces Autoinjector For Treating Anemia
5. Cuba Introduces New Device for Detecting Vascular Diseases
6. China Introduces Solar-powered Baths
7. Allergan Introduces ‘Dermal Filler’ for Smile Lins
8. UAE Introduces Cervical Cancer Vaccine
9. Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation
10. Iceland Introduces Smoking Ban in Bars and Restaurants
11. Indian Introduces Paan-flavoured Condoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)... Mich., Aug. 29 /PRNewswire/ -- In response to rec... chronic wasting disease (CWD),members of the dee...ement., With hunting season fast approaching, the... a deer on a Kent County farm understandably has,c...and deer farmers across,the great state of Michiga...
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... Trusted life science software provid...ents to engage via GSA. , ...ns, an emerging software engineering firm dedicat...U.S. General Services Administration (GSA) Contrac...omers with the ability to conveniently engage 5AM ...
(Date:8/28/2008)... will lead clinical efforts of the Maryland Medica.../ -- KePRO, a national medical,management firm, ap...of,Medical Director. Dr. Lawyer will oversee all c...rmed in KePRO,s Hunt Valley, Maryland Harrisburg,o...cal career in Maryland," said,Alice Stollenwerk Pe...
Breaking Medicine News(10 mins):Health News:Deer Farm Industry in Michigan Issues Statement on the Recent Chronic Wasting Disease Case Identified on a Kent County Deer Farm 2Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2
...er retinoblastoma has been developed by scientists...nstrated// in a mouse model to cause a remarkable ...g the side effects common with standard chemothera...suitable for certain forms of breast, lung, prosta...
...ive pulmonary disease (COPD) attempt to repair dam...s finding is in contradiction with the convention...he finding is important because it could pave the ...on' key genes to allow the lung to grow new alveol...
...haviors of human beings has found that concerns ov...are unfounded.// Monogamy is still held in esteem ...y are published in The Lancet. The research has g...ch found that people were in single relationships ...
... tackled by more action and less talk according to...ter// voiced support for higher taxes on drinks. ...cottish Health Action on Alcohol Problems (SHAAP) ...alth problems and push for action to cut alcohol m...
Other Medicine News:Health News:Revolutionary Eye Cancer Treatment 2Health News:Revolutionary Eye Cancer Treatment 3Health News:Revolutionary Eye Cancer Treatment 4Health News:Lungs repair themselves 2Health News:Alcohol Abuse Must be solved with Action 2
(Date:8/27/2008)...ust 27 /-, - Oralair(R) Gr...Pharmacodynamic Study Conducted in an Allergen Cha...ighly positive results of a new study,conducted in...on Oralair(R) Grasses included 86 adult patients e...eatment durations: 1 week, 1 month,2 and 4 months...
(Date:8/26/2008)...6 /- The Oregon Tourism Commission,la...ervice Training Program,(Q Care) this week on htt...ining program created to support the tourism and,h...ation. By emphasizing,the importance of quality cu...with tools and resources to better serve Oregon,s ...
(Date:8/26/2008)...26 /- Semafore Pharmaceuticals Inc.,p...s on Targeted Therapies,in Cancer in Washington, D...ted kinase inhibitors that demonstrate significant...ovel and proprietary molecular scaffold has been d... the design of pan-PI3 kinase inhibitors,as well a...
(Date:8/26/2008)... 26 /- Cambridge Research &,Instrumen...estro(TM) EX In,Vivo Imaging System. The new syste...ogy and becomes the entry-level instrument of choi...tp://www.newscom.com/cgi-bin/prnh/20080826/NETU054...ancement of CRi,s unique,solid-state tunable optic...
Breaking Medicine Technology:Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Hormonal Changes and Depression 3A What is the Connection 3F 6212 1Hormonal Changes and Depression 3A What is the Connection 3F 6212 2Hormonal Changes and Depression 3A What is the Connection 3F 6212 3Hormonal Changes and Depression 3A What is the Connection 3F 6212 4Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 1Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 2Telomerase enzyme structure provides significant new target for anti cancer therapies 6207 363 percent of diabetics risk serious foot problems by wearing the wrong sized shoes 6202 163 percent of diabetics risk serious foot problems by wearing the wrong sized shoes 6202 2How much fish have we got 3F 1202 1How much fish have we got 3F 1202 2How much fish have we got 3F 1202 3
...primary and secondary endpoints of,study; no negat...opicitabine and ribavirin ~, CAMBRIDGE, Mass., Jun...ceuticals, Inc. today announced results from a pha...n therapy, consisting of,valopicitabine (NM283), I...epatitis C, pegylated interferon and ribavirin,com...
...07 /PRNewswire/ -- Accera, Inc.,today is presentin...Ib clinical trial of AC-1202 (Ketasyn) in Alzheime...International Conference on,Prevention of Dementia...of earlier clinical and preclinical studies, AC-12...ve the memory and,cognition of subjects of a parti...
Other Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 2Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 3Accera, Inc. Announces Open-Label Data from Phase II Study in,Alzheimer's Disease at International Conference on Prevention of,Dementia 4
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value.
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Amvex offers a complete line of flowmeters, available in oxygen, air, heliox and CO 2 . They are all available in a variety of calibrations to best suit your application. With color coded labels and
Medicine Products: